A new series of tetralin-pyridine hybrids was synthesized in good yields starting from 2-(pyridin-2yl)oxy)acetohydrazide as a synthon. The treatment of this acid hydrazide with six different aromatic aldehydes resulted in the formation of the corresponding arylidenehydrazides as cis/trans conformers, which upon treatment with thioglycolic acid afforded 4-thiazolidinone derivatives. The acid hydrazide synthon also reacted with a variety of activated reagents to give the corresponding tetralin-pyridine derivatives in good yields. The in vitro cytotoxic activity of the new compounds were tested showing that these compounds appeared as promising active anti-cancer compounds.
Introduction
Cancer diseases are considered as the second common cause of death after heart disease worldwide. 1, 2 Chemotherapy is still one of the most important roles for cancer treatment. The major issue in the use of chemotherapeutics is the undesirable side effects. Therefore, search for new agents, not only for the treatment of cancer but also to overcome cancer resistance to drug treatment as well as to avoid drug side effects, is a challenge goal.
In this respect, many pyridine derivatives have been synthesized and their biological and chemotherapeutic activities have been investigated and reported. [3] [4] [5] [6] The pyridine moiety is found in many pharmaceutical drugs such as Isoniazid (anti-tuberculosis drug), Omeprazole (antihistaminic drug), Pioglitazone (anti-diabetic drug), Sorafenib and Regorafenib (anticancer drugs) as well as in many agrochemicals such as pyridinenitrile (fungicide), Nitapyrin (bactericide) and Picloram (herbicide). The pyridine motif is also present in a number of biologically active molecules including niacin (vitamin B3), pyridoxine (vitamin B6) and the toxic alkaloid (nicotine) (Figure 1 ). [7] [8] [9] [10] [11] Moreover, tetrahydronaphthalene derivatives have attracted much attention in the medicinal field because of their broad range of pharmacological properties. [12] [13] [14] [15] [16] [17] [18] Furthermore, tetrahydronaphthalene (tetralin) is also an efficient ring, which is found in the structures of some anticancer drugs such as doxorubicin and epirubicin ( Figure 2 ). 19 Scheme 2. Synthesis of compounds 8, 11 and 13.
The cis/trans conformer ratios of the E isomers can easily be determined by 1 H NMR integration. The data obtained from chemical shift values of OCH2, N=CH, and NH protons of cis/trans conformers in the 1 H NMR and that obtained from chemical shift values of OCH2 and N=CH carbons in the 13 C NMR spectra of compounds 8 proved that the E isomers and trans conformer structures (I) are the dominant forms among the four possible structures. [34] [35] [36] [37] In the the trans conformers, the proton signals of N=CH and NH, are shifted upfield compared to those of the cis conformer. On the other hand, because of the steric hindrance, the OCH2 proton signal of the trans conformer is shifted downfield compared to the that of the cis conformer. 34 Scheme 3. E/Z Geometrical isomers and cis/trans amide conformers of compounds 8a-f.
Compounds 8a-f containing imine bond have been synthesized for preparing other derivatives like thiazolidinones due to their broad spectrum of biological activities. 40 Thiazolidinone derivatives belong to the most frequently studied moieties of medicinal interest which attributed to the presence of thiazolidine in the structre of penicillin. 41 The 4-thiazolidinone derivatives 11a and 11c-f were synthesized by refluxing the imine 8a and 8c-f with thioglycolic acid 9 in dry benzene according to the reported method (Scheme 2). 42 The formation of thiazolidinone derivatives were assumed to occur by the addition of the SH group of thioglycolic acid to the CH=N bond of the hydrazine moiety of 8a and 8c-f to yield the corresponding acyclic non-isolable intermediates 10 which underwent the elimination of water molecule by intramolecular cyclization to afford the final cyclocondensation products 11. 43 The structures of the newly synthesized compounds were confirmed by IR, 1 H-NMR and 13 C-NMR as well as elemental analyses. The IR spectra of compounds 11a and 11c-d showed absorption bands at 3435-3441 (NH), 2220-2224 (CN), 1711-1729 (C=O of 4-thiazolidinone ring) and 1675-1685 cm -1 (C=O amide). The 1 H-NMR spectra for 11a and 11c-f showed the two methylene protons of the thiazolidinone ring as doublet of doublets signals at δ 3.73-3.77, 3.85-3.93 ppm and the methine protons as singlet signals at δ 5.68-5.83 ppm. The OCH2 groups appeared as doublet of doublets signals between δ 5.00-5.06, 5.09-5.15 ppm and the NH groups appeared as singlet signals at δ 10.57-10.82 ppm. 13 C NMR spectral data also supports the formation of compounds 11a and 11c-f. Thus, the two carbonyl groups were observed between δ 166. 55-167.11 and 168.21-168 .87 ppm; the SCH 2 CO and the NCHS carbons appeared at δ 32.71- 35.39 ppm and at δ 59.65-65.38 ppm, respectively. Moreover, condensation of 7 with isatin 12 in ethanol at reflux in the presence of a catalytic amount of glacial acetic acid yielded the hydrazone derivative 13. The structure of 13 was confirmed by IR spectrum which showed absorption bands at 3427 and 3212 cm -1 due to (2NH) and at 2228, 1709 and 1657 cm -1 due to CN, C=O of isatin ring and C=O (amide), respectively. Moreover, the 1 H NMR spectrum of 13 showed a D2O-exchangeable NH signal at δ 11.35 ppm characteristic for the NH proton of the isatin moiety. On the other hand, the hydrazine function proton (=N-NH-) appeared as two singlet signals at δ 12.78 and 13.40 ppm, respectively, due to trans/cis conformers. Furthermore, the 13 C NMR spectrum of this compound showed two carbonyl groups at δ 167.90 and 168.75 ppm, confirming the structure of 13 (Scheme 2).
Fusion of a mixture of acetic acid hydrazide 7 and acetic anhydride 14 afforded the new acetic-N'acetyl-2-((3-cyano-4-(4-fluorophenyl)-6- (5,6,7,8-tetrahydronaphthalen-2-yl) pyridin-2yl)oxy)acetohydrazonic anhydride 15 (Scheme 4). The IR spectrum of 15 revealed the presence of two bands at 1742 and 1670 cm -1 due to the acetoxy C=O and the amide C=O, respectively, which is in agreement with that reported in the literature. 44 In addition, the 1 H NMR spectrum of 15 showed two methyl protons at δ 2.34 ppm and at δ 2.35 ppm for NHCO-CH3 and for OCO-CH3, respectively. Likewise, the 13 C NMR spectrum of 15 showed the two methyl carbons of the acetoxy and the acetamide groups at δ 22.49 and 22.58 ppm, respectively, in addition to the two carbonyl groups at δ 168.63 and 170.56 ppm, respectively.
Benzoylation of 7 was achieved via its reaction with benzoyl chloride 16 in refluxing pyridine to give N'- (2-((3-cyano-4-(4-fluorophenyl)-6-(5,6,7,8-tetrahydronaphthalen-2-yl) pyridin-2yl)oxy)acetyl)benzohydrazide 17 (Scheme 4).
The IR spectrum of compound 17 revealed strong absorption bands at υ 3432, 3230, 1728 and 1716 cm -1 attributable to two NH groups and two C=O groups, respectively. The 1 H NMR spectrum of compound 17 revealed two singlets at δ 10.37 and δ 10.46 ppm assigned to the two NH protons, in addition to multiplet signals in the region δ 7.45-7.99 ppm characteristic to the aromatic protons. 13 C NMR spectrum of 17 gave a further evidence for its structure as it showed the two carbonyl groups at δ 165.36 and 168.08 ppm, respectively.
Our study was extended to include the synthesis of 2-((3-cyano-4-(4-fluorophenyl)-6-(5,6,7,8tetrahydronaphthalen-2-yl)pyridin-2-yl)oxy)-N'-formylacetohydrazide 19 in good yields by heating acetohydrazide 7 with formic acid 18 at reflux (Scheme 4). The IR spectrum of compound 19 displayed an absorption band at 1724 cm -1 corresponding to the carbonyl C=O of the formyl group, which appeared in the 13 C NMR spectrum at δ 169.7 ppm. Its 1 H NMR spectrum revealed a singlet at δ 8.04 ppm assigned to the formyl proton. Methyl (pyridin-2-yl)oxy)acetyl)hydrazine-1-carbodithioate 20 was also synthesized by the reaction of acetohydrazide 7 with carbon disulfide and methyl iodide in ethanolic solution in the presence of triethylamine (TEA), according to the reported method. 45 The structure of this compound was confirmed according to its correct analytical and spectroscopic data. The 1 HNMR spectrum of 20 showed signals at δ 10.76 and at δ 10.80 assigned for two NH protons and at 2.56 ppm corresponding to -SCH3 group while its carbon appeared at δ 19.56 ppm in the 13 C NMR in addition to the C=S which appeared at δ 205.10 ppm. Further structural verification was obtained from its mass spectroscopy, which showed the correct molecular ion peak at m/z 506.30 (M + , 100).
The acetohydrazide derivative 7 is also a very useful intermediate for further cyclocondensation reactions. Thus, cyclocondensation of 7 with acetylacetone 21 afforded the corresponding dimethylpyrazole derivative 23 as a single product via initial formation of the intermediate hydrazone 22 43 (Scheme 5). The structure of compound 23 was confirmed based on the IR, 1 H NMR, 13 C NMR and mass spectral data, which were in agreement with the assigned structure. Thus, the absence of signals corresponding to NH, NH2 protons in both the IR and 1 H NMR spectra confirmed that they were involved in the cyclization. Also, 1 H-NMR spectrum of 23 showed two singlets at δ 2.29 ppm and 2.45 ppm characteristic for the two CH3 groups and a singlet at δ 6.35 ppm due to the H-4 of the pyrazole moiety. The 13 C NMR spectral of 23 revealed two characteristic singlets at δ 150.45 and 154.54 ppm for C3 and C5 of the pyrazole nucleus, respectively, in addition to the two methyl groups at δ 13.56 and 13.60 ppm.
Scheme 5. Synthesis of compounds 23 and 26.
Furthermore, cyclocondensation of 7 with ethyl cyanoacetate in ethanol containing KOH at reflux gave a novel pyrazole derivative 26. The formation of this compound proceeded through nucleophilic transformation to give the non-isolable acyclic intermediate 24, followed by intramolecular cyclization via loss of ethanol molecule and tautomerization under the reaction conditions to give 25. Subsequent acetylation of the amino group of 25 afforded the final product 26 in a good yield (Scheme 5). The structure of 26 was confirmed based on its correct analytical and spectral data. Its IR spectrum showed absorption bands at υ 3440 (OH), 3196 (NH), 2218 (CN) and 1606 (C=O) cm -1 . Also, the 1 H-NMR spectrum of compound 26 indicated the presence of a singlet signal integrated by three protons at δ 1.87 ppm for COCH 3 protons, and a singlet signal integrated by two protons at δ 5.11 ppm assigned to methylene protons. In addition, the aromatic protons as well as the pyrazole-H4 appeared at δ 7.42-7.93 ppm, in addition to signals at δ 9.89 and 10.21 ppm characteristic for NH and OH groups, respectively.
On the other hand, attempted synthesis of pyrazole 29 via the reaction of acetohydrazide 7 with [bis(methylthio)methylene] malononitrile 27 in ethanol was unsuccessful. The reaction gave instead the oxadiazole derivative 30. The reaction seems to proceed via initial formation of the expected acyclic intermediate 2-((3-cyano-4-(4-fluorophenyl)-6- (5,6,7,8-tetrahydronaphthalen-2-yl) pyridin-2-yl)oxy)-N'-(2,2-dicyano-1-(methyl-thio)vinyl)acetohydrazide 28, which upon intramolecular nucleophilic cyclization by elimination of methylthiol molecule afforded the oxadiazol derivative 30 (Scheme 6). The absence of sulfur element in the product of this reaction together with the disappearance of the amino NH2 group in both IR and 1 H-NMR as well as the disappearance of C=O in both the IR and 13 C-NMR spectra confirmed the exclusion of 29. Moreover, 1 H-NMR and 13 C-NMR spectra revealed the loss of the methylthio groups that can be considered as a strong evidence for the formation of the oxadiazol derivative 30 which in agreement with that related in the literature. 43 Scheme 6. Synthesis of compound 30 from acetohydrazide 7.
In-vitro cytotoxicity activities
The in vitro cytotoxic activity of twenty compounds of the synthesized compounds were evaluated against human colorectal carcinoma cell line (HCT116) and human breast cancer cell line (MCF-7) using MTT assay. The percentages of the viable cells was measured and compared to that obtained by the positive control Doxorubicin ® (Fig.3,4) . The cytotoxic activities of the tested compounds were also expressed as IC50 µM values (the dose that reduces survival to 50%). Regarding the activity of the evaluated compounds against HCT116 cancer cells, the results in Table 1 showed that the compounds possessed high cytotoxicity approximately equal to that obtained by doxorubicin (IC50; 7.7-9.0 µM, IC50 doxorubicin; 8.0 µM). Concerning MCF-7 cancer cells, it is evident that there is a wide variation in the cytotoxic potency of the tested compounds. Interestingly, the N'-formylacetohydrazide derivative 19 was approximately three times more active than DOX (IC50; 21.0 µM, IC50 doxorubicin; 68.4 µM). On the other hand, the activity decreased slightly by the acetohydrazonic anhydride derivative 15 to be twice that of the reference drug (IC50; 33.3 µM). Although linking the thiazolidinone ring to the oxyacetamide side chain as compound 11c led to a decrease in the potency, but it is still a promising antitumor agent comparable to DOX (IC50; 60.3 µM). It could be noted that the starting acetohydrazide compound 7 and its p-fluorophenyl shiff , s base analogue 8a appeared to be slightly less potent cytotoxic candidates than DOX of IC50 values; 72.7 and 71.0 µM, respectively. The results also showed that the rest of the tested derivatives were weaker than DOX of IC 50 values ranging from 78.0-110.9 µM. It could be concluded that tetralin-pyridine backbone is an interesting antitumor pharmacophore against the breast cancer cells (MCF-7). The above mentioned data reveal that all the evaluated compounds are more active against the human colon cancer type rather than against the human breast cancer type. Further structural modifications and optimization are needed to signify and widen the antitumor spectrum of the derivatives bearing tetralin-pyridine motif. 
Conclusions
We successfully synthesized a new series of tetralin-pyridine hybrids in good yields by reacting 2-((3cyano-4-(4-fluorophenyl)-6- (5,6,7,8-tetrahydronaphthalen-2-yl) pyridin-2-yl)oxy)acetohydrazide with a variety of reagents. The structures of the new compounds were confirmed by spectral data as well as elemental analyses. Study of the cytotoxic activity of the new compounds on HCT116 and MCF-7 human cancer cells using MTT assay revealed that these compounds are potent cytotoxic on the human colon cancer type and some of them showed good activities against breast cancer in vitro. Finland) with a 5 mm BBFO probe using deuterated dimethylsulfoxide DMSO as a solvent and the chemical shifts were expressed in δ ppm relative to TMS as an internal reference. Mass spectra were recorded at 70 eV on EI Ms-QP 1000 EX (Shimadzu, Japan), NRC. Follow-up of the reactions and checking of the purity of the compounds were made by TLC on silica gel precoated aluminum sheets (Type 60, F 254, Merck, Darmstadt, Germany) and the spots were detected by exposure to a UV lamp at 254 nm for a few seconds. The chemical names for the prepared compounds are given according to the IUPAC system . Compounds 1 29 , 4, 6 and 7 were prepared as reported in the literature. 30, 31 General procedure for synthesis of compounds (8a-f) A mixture of acetohydrazide (7) (0.4165 g, 1 mmol) and the appropriate aromatic aldehyde namely: 4fluorobenzaldehyde (2a), benzaldehyde (2b), 4-bromobenzaldhyde (2c), 4-chlorobenzaldehyde (2d), 4cyanobenzaldhyde (2e) and 4-methoxybenzaldehyde (2f) (1 mmol) in absolute ethanol (30 ml) , was treated with acetic acid (0.5 mL). The clear solution was then heated at reflux for 6 h. The solid precipitate so formed during the course of the reaction on heating was collected by filtration, washed by hot ethanol and crystallized from acetic acid to give the benzylidene derivatives 8a-f. 43, 106.06, 115.77, 115.99, 124.43, 129.35, 131.07, 131.16, 132.17 , 133.46, 137.08, 139.98, 155.24, 157.08, 162.56, 162.25) , 4.63; F, 7.27; N, 10.72; Found: C, 71.19; H, 4.58; F, 7.25; N, 10.79 . N'-Benzylidene-2-((3-cyano-4-(4-fluorophenyl)-6-(5,6,7,8-tetrahydronaphthalen-2-yl)pyridin-2-yl) 24, 103.54, 115.75, 115.97, 124.44, 129.73, 131.07, 131.16, 133.45, 133.99, 135.11, 137.08, 155.24, 157. 368.43 (58), 358.22 (100) , 357 (70), 327.30 (58) ; Analysis calcd. for: C32H24FN5O2 (529.58): C, 72.58; H, 4.57; F, 3.59; N, 13.22; Found: C, 72.47; H, 4.49; F, 3.53; N, 13.31 38, 106.08, 114.17, 116.73, 122.38, 126.46, 129.32, 130.34, 133.38, 134.00, 136.63, 156.93, 157.77, 162.75, 163.64, 164. General procedure for synthesis of thiazolidinone 11a and 11c-f. A solution of Schiff bases (8a and 8c-f) (0.001 mol), and thioglycolic acid (9) (0.165 g; 0.0015 mol), in dry benzene (50) mL was heated at refluxed for 6 h. Progress of the reaction was checked by TLC using benzene-ether as eluent. After evaporation of the solvent under reduced pressure, the resulting viscous liquid was treated with saturated sodium bicarbonate solution to remove unreacted thioglycolic acid. The product separated out was washed with water, dried and recrystallized from ethanol to afford compounds 11a and 11c-f. 46, 115.77, 124.53 , 127.38, 129.40 , 131.02, 132.06, 133.17, 134 , 135.12 , 136.01, 157.35 , 157.76 , 163.15, 164.89 , 4.39; F, 6.37; N, 9.39; S, 5.37; found: C, 66.38; H,4.28; F, 6.17; N, 9.48; S, 5.24 . N-(2-(4-Bromophenyl)-4-oxothiazolidin-3-yl)-2-((3-cyano-4-(4-fluorophenyl)-6-(5,6,7,8-tetrahydro Then, media were removed, MTT (40 µL of 2.5 mg/mL) was added to each well and incubated for 4 hours. 200 µL of DMSO were added to solubilize the formazan dye crystals (purple color). Using a SpectraMax ® Paradigm ® Multi-Mode microplate reader, the absorbance was measured at 570 nm. Each experiment was repeated on three different days and conducted in triplicate. The relative cell cytotoxicity was measured according to the following equation: % cytotoxicity = (1 -As/Ab)*100 Where; As = Absorbance of each sample and Ab = Absorbance of the blank. The probit analysis using the SPSS software program (version 20, SPSS Inc., Chicago, IL, USA) was used to determine each IC50.
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